Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection
- PMID: 24388650
- PMCID: PMC4051704
- DOI: 10.1016/S1472-9792(13)70011-8
Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection
Abstract
Mycobacterium tuberculosis (Mtb) is the causative agent of human tuberculosis (TB) with an estimated 8.8 million new TB cases and 1.4 million deaths annually. Tuberculosis is the leading cause of death in AIDS patients worldwide but very little is known about early TB infection or TB/HIV co-infection in infants. A clinically relevant newborn animal model to study TB infection is urgently needed. We have successfully established an aerosol newborn/infant model in neonatal nonhuman primates (NHPs) that mimics clinical and bacteriological characteristics of Mtb infection as seen in human newborns/infants. Further, this model will allow the establishment of a TB coinfection model of pediatric AIDS. Aerosol versus intra broncho-alveolar Mtb infection was studied. Interestingly, 42 days post infection specific lesions were detected suggestive of the classic Ghon focus in human children. Concurrently, specific cellular immune responses developed 4-6 weeks after Mtb infection. Using the enzyme-linked immunospot (ELISPOT) assays, we found that IL-12 production correlated with early Mtb infection lesions seen by routine thoracic radiographs. Overall, this work represents the first example of early Mtb infection of newborn macaques. This study gives us a unique opportunity to further characterize immunopathogenesis and establish a TB/SIV co-infection model for pediatric AIDS.
Keywords: ELISPOT IL-12; Ghon focus; TB; newborn; rhesus macaque.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None declared.
Figures
References
-
- Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rusch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2011;38:516–28. - PubMed
-
- Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY, Gernaey AM, Galili E, Eshed V, Greenblatt CL, Lemma E, Bar-Gal GK, Spigelman M. Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PloS one. 2008;3:e3426. - PMC - PubMed
-
- David ST, Mukundan U, Brahmadathan KN, John TJ. Detecting mycobacteraemia for diagnosing tuberculosis. The Indian journal of medical research. 2004;119:259–66. - PubMed
-
- Galimi R. Extrapulmonary tuberculosis: tuberculous meningitis new developments. European review for medical and pharmacological sciences. 2011;15:365–86. - PubMed
-
- Huebner RE, Castro KG. The changing face of tuberculosis. Annual review of medicine. 1995;46:47–55. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
